Selected-GenAtlas references SOURCE GeneCards NCBI Gene Swiss-Prot Ensembl
HGNC UniGene Nucleotide OMIM UCSC
Home Page
FLASH GENE
Symbol TCL1A contributors: mct/pgu - updated : 01-10-2013
HGNC name T-cell leukemia/lymphoma 1A
HGNC id 11648
Corresponding disease
TCL1A T-CLL chronic lymphocytic leukemia
Location 14q32.13      Physical location : 96.176.304 - 96.180.533
Synonym name
  • T-cell lymphoma 1
  • oncogene TCL1
  • protein p14 TCL1
  • Synonym symbol(s) TCL1
    DNA
    TYPE anonymous DNA segment
    STRUCTURE 4.23 kb     4 Exon(s)
    10 Kb 5' upstream gene genomic sequence study
    regulatory sequence Promoter (TATA box)
    text structure 5'-TCL1 promoter region contains a TATA box with cis-regulatory elements for Nur77/NGFI-B (nerve growth factor-responsive element (NBRE), CCAAGGTCA), NFkappaB, and fork head transcription factor (nerve growth factor-responsive element being a negative regulatory element)
    MAPPING cloned Y linked   status confirmed
    RNA
    TRANSCRIPTS type messenger
    identificationnb exonstypebpproduct
    ProteinkDaAAspecific expressionYearPubmed
    4 - 1405 - 114 - 2000 10983986
    4 - 1410 - 114 - 2000 10983986
    EXPRESSION
    Type restricted
       expressed in (based on citations)
    organ(s)
    SystemOrgan level 1Organ level 2Organ level 3Organ level 4LevelPubmedSpeciesStageRna symbol
    Lymphoid/Immunelymph node    
     tonsils    
    Respiratorylung    
    tissue
    SystemTissueTissue level 1Tissue level 2LevelPubmedSpeciesStageRna symbol
    Blood / Hematopoieticbone marrow   
    Muscularstriatumskeletal  
    cells
    SystemCellPubmedSpeciesStageRna symbol
    Lymphoid/ImmuneB cell Homo sapiens
    cell lineage
  • normally in pre-B cells and immature IgM expressing B cells and in early T cell progenitors with very low levels in bone marrow and peripheral lymphocytes
  • cell lines
    fluid/secretion
    at STAGE
    PROTEIN
    PHYSICAL PROPERTIES
    STRUCTURE
    motifs/domains
    mono polymer homomer , heteromer , dimer , trimer
    HOMOLOGY
    intraspecies homolog to MTCP1
    Homologene
    FAMILY TC11 family
    CATEGORY protooncogene
    SUBCELLULAR LOCALIZATION     intracellular
    intracellular,cytoplasm,organelle,membrane
    intracellular,cytoplasm,organelle,endoplasmic reticulum
    intracellular,cytoplasm,cytosolic,microsome
    intracellular,nucleus
    text
  • localizes in both nucleus and cytoplasm
  • basic FUNCTION
  • stabilizing the mitochondrial transmembrane potential and enhancing cell proliferation and survival
  • AKT kinase coactivator
  • inhibits DNA methylation, in aggressive B-cell chronic lymphocytic leukemia
  • is naturally processed and presented on the surface of lymphoma cells for recognition by cytotoxic T cells
  • CELLULAR PROCESS cell life, differentiation
    PHYSIOLOGICAL PROCESS
    PATHWAY
    metabolism
    signaling
    a component AKT1/TCL1A multimeric complex activating AKT
    INTERACTION
    DNA
    RNA
    small molecule
    protein
  • coactivator of AKT
  • physically interacts with c-Jun, JunB, and c-Fos and inhibits AP-1 transcriptional activity
  • binds specifically and directly to the ankyrin domain of IKBKB, the inhibitor of the NF-kappaB transcription factors
  • role of TCL1A in PTPROt suppression, important in the pathogenesis ofchronic lymphocytic leukemia (CLL)
  • physically interacts with DNA methylthansferases DNMT3A and DNMT3B
  • TCL1A and ATM functionally cooperate to modulate similar apoptosis-related cellular pathways
  • functional interaction between TCL1A and HSPA4 and TCL1A is a novel HSPA4 client protein
  • cell & other
    REGULATION
    ASSOCIATED DISORDERS
    corresponding disease(s) TCL1A
    Other morbid association(s)
    TypeGene ModificationChromosome rearrangementProtein expressionProtein Function
    tumoral     --other  
    dysregulated in T cell lymphoma
    tumoral     --over  
    in mature B cell lymphoma
    tumoral     --over  
    in T-cell prolymphocytic leukemia
    tumoral     --over  
    causes B-CLL by directly enhancing NFKB activity and inhibiting AP-1
    tumoral     --other  
    TCL1A dysregulation in B cells is responsible for the development of an aggressive form of chronic lymphocytic leukemia (CLL), the most common human leukemia
    Susceptibility
    Variant & Polymorphism
    Candidate gene
    Marker
  • diagnostic marker used in the differential diagnosis of splenic low-grade B-cell lymphoma
  • Therapy target
    SystemTypeDisorderPubmed
    cancerhemopathy 
    target for development of immunotherapeutic strategies against common B-cell lymphomas
    ANIMAL & CELL MODELS